|
(P454) |
Nitrate-stimulated tilt testing with and without a preceding passive phase: results of a prospective randomized trial |
| |
|
D. Erkapic, A. Wolf, K. Weipert, I. M. Helmig, G. Abaci, R. Chasan, C. Gemein, A. Kelava, T. Neumann, C. W. Hamm, J. Schmitt (Gießen, Bad Nauheim) |
|
(P455) |
Digoxin-associated mortality: A comprehensive meta-analysis of the literature |
| |
|
M. Vamos, J. Erath, S. Hohnloser (Frankfurt am Main) |
|
(P456) |
Effektivität und Verträglichkeit von Dronedaron bei Patienten mit paroxysmalem oder persistierendem Vorhofflimmern unter Praxis-bedingungen: IMPULS-Studie |
| |
|
R. Bosch, G. Benninger, D. Pittrow, W. D. Paar, B. von Stritzky, A. Götte (Ludwigsburg, Münster, Dresden, Berlin, Paderborn) |
|
(P457) |
Characterization and Significance of Accessory Pathway Dormant Conduction in Patients with WPW Syndrome |
| |
|
D. Kämpfner, C. Theis, T. Konrad, S. Sonnenschein, H. Mollnau, K. Bock, B. Quesada Ocete, S. Gerhardt, E. Himmrich, T. Münzel, T. Rostock (Mainz) |
|
(P458) |
Nitro Oleic Acid prevents ROS production in a murine model of atrial fibrillation by reducing differentiation of cardiac fibroblasts and activation of macrophages |
| |
|
T. Ravekes, A. Klinke, K. Friedrichs, M. Pekarova, B. A. Freeman, S. Baldus, V. Rudolph, T. K. Rudolph (Köln; Brno, CZ; Pittsburgh, US) |
|
(P459) |
Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: first experimental insights into a novel antiarrhythmic agent |
| |
|
G. Frommeyer, M. Schmidt, D. Dechering, S. Kochhäuser, F. Reinke, P. Milberg, L. Eckardt (Münster, Osnabrück) |
|
(P460) |
Dabigatran enhances TRAP induced platelet aggregation in cardiac patients |
| |
|
C. Olivier, P. Weik, M. Meyer, U. Geisen, P. Diehl, Q. Zhou, C. Bode, M. Moser (Freiburg im Breisgau) |
|
(P461) |
Severe proarrhythmic potential of ondansetron in an experimental whole-heart model of proarrhythmia |
| |
|
G. Frommeyer, C. Fischer, S. Kaese, F. Reinke, P. S. Lange, H. Bogossian, P. Milberg, L. Eckardt (Münster, Lüdenscheid, Osnabrück) |
|
(P462) |
Does physiological withdrawal of estrogen have a disadvantage for women? : The relationship between postmenopausal obesity and CaMKII via p38MAPK pathway in the atrium. |
| |
|
T. Tsuneda, S. Neef, T. Islam, L. S. Maier (Göttingen, Regensburg) |
|
(P463) |
Safe electrophysiologic profile of quetiapine in contrast to haloperidol in an experimental whole-heart model |
| |
|
G. Frommeyer, B. Brücher, H. von der Ahe, S. Kaese, P. S. Lange, D. Dechering, H. Bogossian, P. Milberg, L. Eckardt (Münster, Lüdenscheid, Osnabrück) |
|
(P464) |
Platelet reactivity in interventional patent foramen ovale/ atrium septum defect closure |
| |
|
A. Polzin, V. Popp, M. Kelm, T. Zeus (Düsseldorf) |
|
(P465) |
Postinterventionelle Thrombembolieprophylaxe nach endovaskulärem LAA-Verschluss mit Apixaban und ASS |
| |
|
M. Christoph, C. Wunderlich, Y. Huo, M. Forkmann, J. Mayer, C. Piorkowski, M. Pohl, K. Ibrahim, T. Gaspar (Dresden) |